A Kenyan court stepped in at the eleventh hour to block a quarantine facility that would have housed Americans exposed to Ebola, halting a Trump administration plan on the very day it was set to open. The decision, handed down by a judge on Friday, represents a rare moment when constitutional accountability prevailed over government expediency—and a vindication of the Kenyan activists who challenged the plan in court.

The backdrop was an Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda, where the Bundibugyo virus strain had claimed nearly 250 lives and sickened more than 1,000 people. U.S. officials proposed building a makeshift field hospital at Laikipia Air Base, about 125 miles from Nairobi, Kenya's capital, to quarantine exposed or infected American citizens. The facility would have been staffed by U.S. Public Health Service officers. While Kenya's government initially agreed to the plan, it sparked fierce public backlash and constitutional concerns that ultimately reached the courts.

The Katiba Institute, a constitutional rights advocacy group, filed a petition arguing that the plan posed a direct threat to Kenyan citizens. In their view, the case transcended the immediate health question: "At its core," the group wrote, "the case is about preserving constitutional accountability, protecting public health and ensuring that no government may place expediency above the lives and safety of the people of Kenya." They urged the court to bar individuals exposed to or infected with Ebola from entering the nation and to demand that Kenya's Health Ministry present a contingency plan and publicly disclose the terms of any agreement.

The plan itself raised uncomfortable ethical questions about overseas medical care. The Trump administration maintained that the field hospital would provide respiratory support and hydration on site, with Americans requiring advanced care evacuated to specialized facilities in Europe—a route officials argued was safer and faster than transporting patients on long flights back to the United States. Patients would be treated with monoclonal antibodies and remdesivir, an antiviral drug not officially approved for Ebola but commonly used off-label. Yet public health experts worried that care at a field hospital in Kenya would prove inferior to treatment available at specialized U.S. medical units.

The judge's ruling on Friday effectively halted the plan: no one from Ebola-affected regions would be allowed to enter Kenya, and the facility would not open pending a court hearing scheduled for June 2. The decision came as the CDC reported no Ebola cases associated with the outbreak in the United States, with the agency noting that risk to the general public remains low.

The outcome reflects a broader tension between government efficiency and constitutional protection—one that Kenya's courts decided to resolve in favor of its citizens' rights. For the Katiba Institute and the Kenyan public that supported the legal challenge, Friday's ruling was a reminder that even when governments agree to a plan, courts can and should scrutinize whether that plan honors the fundamental commitments made to the people a nation serves.